entertainment -WSS

entertainment

author：hotspot 2025-09-06 03:56:19 - browse：8672

What is the best way to fix faulty blood cells, and do so for the most people? That’s the question a horde of gene editing researchers are chasing. A new paper in Science offers an idea.

Researchers loaded up lipid nanoparticles, the tiny clusters of fat, with cellular instruction manuals in the form of mRNA — the same basic construction as the Covid mRNA vaccines. The surface of these therapeutic bundles were decorated with antibodies that guide them to hematopoietic stem cells in the bone marrow. Once there, they delivered gene editing technology packed into the mRNA and corrected sickle cell defects in mice and in human cells.

“What really struck me was, damn, how efficient it is,” said Paula Cannon, a gene therapy researcher at the University of Southern California’s Keck School of Medicine who was not involved with the paper.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Continuity nursing helped my family in our darkest PICU moments
Next article： Police still searching for prisoner who escaped from NYC hospital

WSS

Key House panel plots a new health care package

FDA approves RSV monoclonal antibody for infants, toddlers

Hawaii wildfires fueled by Hurricane Dora's winds prompt evacuations

Anavex keeps shifting the goalposts in its clinical trials

FDA moves to stop vape shops from selling Elf Bar, Esco Bars

Doctors find melanoma drugs effective against rare brain cancer

hotspot

entertainment

knowledge

After affirmative action ruling, medical educators look to 'holistic review'

Shkreli is convicted of fraud. Can pharma finally slam the door on him?

Moonlake's readout produced a cash windfall. Risks remain

Detailed data confirm benefits, risks of Eli Lilly's Alzheimer's drug

Jerome Adams on the need for new antivirals for Covid

Listen: Wegovy in the brain & pivotal Alzheimer's data

Supreme Court strikes down use of affirmative action

FDA moves to stop vape shops from selling Elf Bar, Esco Bars

Medicare proposal to cover medical devices draws a mixed reaction

Whistleblower: Blue Cross Blue Shield evaded $170 million in taxes

leisure time

FDA moves to stop vape shops from selling Elf Bar, Esco Bars

Emergent cuts jobs, executive role in business shake

EHR maker NextGen Healthcare to pay $31M to resolve fraud claims

A biotech analyst on neuroscience, placebo effect, not over

Why hospitals are withdrawing from US News rankings

How to use technology to prevent future drug shortages

explore

hotspot

focus

hotspot